Plasma amino-acids in hereditary retinal disease. Ornithine, lysine, and taurine
- PMID: 1268174
- PMCID: PMC1042687
- DOI: 10.1136/bjo.60.2.142
Plasma amino-acids in hereditary retinal disease. Ornithine, lysine, and taurine
Abstract
Plasma free amino-acids were measured in 41 patients with hereditary chorio-retinal degenerations including 26 with retinitis pigmentosa and five with gyrate atrophy of the choroid, six relatives of patients with gyrate atrophy, and 13 normal subjects. Patients with gyrate atrophy had very increased levels of ornithine and slightly decreased mean lysine values. Most relatives had slightly increased ornithine. Taurine, known to be deficient in the plasma of casein-fed cats with photoreceptor degeneration, was normal in all patients. Amino-acid precursors and metabolites of ornithine and taurine were also normal in the plasma. Although the association of high ornithine and gyrate atrophy appears constant, high levels of ornithine alone do not necessarily lead to this degeneration; one patient with known hyperammonaemia, homocitrullinuria and a tenfold increase in plasma ornithine was found to have a normal fundus appearance and normal electroretinogram.
Similar articles
-
Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet.J Clin Invest. 1980 Feb;65(2):371-8. doi: 10.1172/JCI109680. J Clin Invest. 1980. PMID: 7356686 Free PMC article.
-
Raised plasma-ornithine and gyrate atrophy of the choroid and retina.Lancet. 1973 May 12;1(7811):1031-3. doi: 10.1016/s0140-6736(73)90667-3. Lancet. 1973. PMID: 4122112 No abstract available.
-
Myopathy in hyperornithinemic gyrate atrophy of choroid and retina.Isr J Med Sci. 1981 Apr;17(4):271-6. Isr J Med Sci. 1981. PMID: 6786998
-
Retinal risks of high-dose ornithine supplements: a review.Br J Nutr. 2011 Sep;106(6):801-11. doi: 10.1017/S0007114511003291. Epub 2011 Jul 18. Br J Nutr. 2011. PMID: 21767450 Review.
-
Management of hereditary retinal degenerations: present status and future directions.Surv Ophthalmol. 1999 Mar-Apr;43(5):427-44. doi: 10.1016/s0039-6257(99)00006-5. Surv Ophthalmol. 1999. PMID: 10340561 Review.
Cited by
-
Taurine Supplementation as a Neuroprotective Strategy upon Brain Dysfunction in Metabolic Syndrome and Diabetes.Nutrients. 2022 Mar 18;14(6):1292. doi: 10.3390/nu14061292. Nutrients. 2022. PMID: 35334949 Free PMC article. Review.
-
Treatment of gyrate atrophy of the choroid and retina with low arginine diet.Trans Am Ophthalmol Soc. 1980;78:226-42. Trans Am Ophthalmol Soc. 1980. PMID: 7257057 Free PMC article.
-
Cloning and expression of a cDNA encoding the transporter of taurine and beta-alanine in mouse brain.Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12145-9. doi: 10.1073/pnas.89.24.12145. Proc Natl Acad Sci U S A. 1992. PMID: 1465453 Free PMC article.
-
Amino acids in retinitis pigmentosa.Br J Ophthalmol. 1981 Sep;65(9):626-30. doi: 10.1136/bjo.65.9.626. Br J Ophthalmol. 1981. PMID: 7295629 Free PMC article.
-
Gyrate atrophy of the choroid and retina: amino acid metabolism and correction of hyperornithinemia with an arginine-deficient diet.J Clin Invest. 1980 Feb;65(2):371-8. doi: 10.1172/JCI109680. J Clin Invest. 1980. PMID: 7356686 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous